FN1 and glioblastoma: Regarding the role of fibronectins in the brain, EDB-FN is suggested for use as a tracing tool to diagnose primary GBM in patients 14 and as a novel target for GBM treatment, glioma radioimmunotherapy, in a rodent model 15, 16.